Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ripasudil

A Rho-kinase (ROCK) inhibitor eye drop, approved in Japan in 2014 for glaucoma and ocular hypertension: it lowers eye pressure by increasing the outflow of aqueous humour through the trabecular meshwork. This family brings together the active ingredient and other impurities.

Did you know?It was born from a small change to fasudil, another Rho-kinase inhibitor: adding one fluorine atom and one methyl group made it much more potent and selective.

RipasudilGo to the active ingredient →
RipasudilActive ingredientRipasudilCat. No. P-R065-001CAS 223645-67-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.